An open-label Phase I/II clinical trial of pyrimethamine...

An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay–Sachs or Sandhoff variants)

Joe T.R. Clarke, Don J. Mahuran, Swati Sathe, Edwin H. Kolodny, Brigitte A. Rigat, Julian A. Raiman, Michael B. Tropak
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
102
Year:
2011
Language:
english
DOI:
10.1016/j.ymgme.2010.09.004
File:
PDF, 340 KB
english, 2011
Conversion to is in progress
Conversion to is failed